Previous 10 | Next 10 |
home / stock / cdmo / cdmo articles
Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better-than-expected...
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.1% points on Thursday. Shares of Victoria's Secret &am...
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufact...
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confide...
Shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) moved lower during Friday’s session following weak quarterly earnings. Comtech Tele...
Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter. The company said net revenue...
Avid Bioservices Inc (NASDAQ: CDMO) reported Q2 FY24 sales of $25.4 million, down 27% Y/Y, primarily attributed to fewer year-to-date manufact...
U.S. stock futures traded mixed this morning, with the Dow Jones futures gaining around 15 points on Friday. Shares of RH (NYSE: RH) shares moved ...
U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 50 points on Monday. Shares of Alaska Air Group, Inc. (N...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
14.93%Change Percent:
Avid Bioservices Inc. Company Name:
CDMO Stock Symbol:
NASDAQ Market:
Avid Bioservices Inc. Website:
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditur...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announc...